The rs2147578 C > G polymorphism in the Inc-LAMC2–1:1 gene is associated with increased neuroblastoma risk in the Henan children

[1] Brodeur GM(2003)Neuroblastoma: biological insights into a clinical enigma Nat Rev Cancer 3 203-216

[2] Kamijo T(2012)Molecular and genetic bases of neuroblastoma Int J Clin Oncol 17 190-195

[3] Nakagawara A(2009)Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the international neuroblastoma risk group database J Clin Oncol 27 365-370

[4] Bagatell R(2009)The international neuroblastoma risk group (INRG) classification system: an INRG task force report J Clin Oncol 27 289-297

[5] Beck-Popovic M(2009)The international neuroblastoma risk group (INRG) staging system: an INRG task force report J Clin Oncol 27 298-303

[6] London WB(2005)PHOX2B genotype allows for prediction of tumor risk in congenital central hypoventilation syndrome Am J Hum Genet 76 421-426

[7] Zhang Y(2006)PHOX2B analysis in non-syndromic neuroblastoma cases shows novel mutations and genotype-phenotype associations Am J Med Genet A 140 1297-1301

[8] Pearson AD(2008)Identification of ALK as a major familial neuroblastoma predisposition gene Nature 455 930-935

[9] Matthay KK(2008)High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours Biochem J 416 153-159

[10] Cohn SL(2008)Activating mutations in ALK provide a therapeutic target in neuroblastoma Nature 455 975-978

[1] Brodeur GM(2003)Neuroblastoma: biological insights into a clinical enigma Nat Rev Cancer 3 203-216

[2] Kamijo T(2012)Molecular and genetic bases of neuroblastoma Int J Clin Oncol 17 190-195

[3] Nakagawara A(2009)Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the international neuroblastoma risk group database J Clin Oncol 27 365-370

[4] Bagatell R(2009)The international neuroblastoma risk group (INRG) classification system: an INRG task force report J Clin Oncol 27 289-297

[5] Beck-Popovic M(2009)The international neuroblastoma risk group (INRG) staging system: an INRG task force report J Clin Oncol 27 298-303

[6] London WB(2005)PHOX2B genotype allows for prediction of tumor risk in congenital central hypoventilation syndrome Am J Hum Genet 76 421-426

[7] Zhang Y(2006)PHOX2B analysis in non-syndromic neuroblastoma cases shows novel mutations and genotype-phenotype associations Am J Med Genet A 140 1297-1301

[8] Pearson AD(2008)Identification of ALK as a major familial neuroblastoma predisposition gene Nature 455 930-935

[9] Matthay KK(2008)High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours Biochem J 416 153-159

[10] Cohn SL(2008)Activating mutations in ALK provide a therapeutic target in neuroblastoma Nature 455 975-978